Simon Boyi Chen MD
Molecular Genetics, Clinical Pathology
Molecular Pathologist
Join to View Full Profile
Perelman School of Medicine, University of PennsylvaniaPhiladelphia, PA 19104
Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Interests: molecular genetic pathology, blockchain applications in pathology, artificial intelligence applications in pathology
Education & Training
Stanford Health Care-Sponsored Stanford University Surgical PathologyFellowship, Selective Pathology, 2021 - 2022- Stanford Health Care-Sponsored Stanford UniversityFellowship, Molecular Genetic Pathology, 2020 - 2021
- Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 2016 - 2020
Washington University in St. Louis School of MedicineClass of 2016, MD
University of TorontoHonours Bachelor of Science, Biological Chemistry, High Distinction, 2008 - 2012
Certifications & Licensure
CA State Medical License 2017 - 2026
PA State Medical License 2022 - 2026
NJ State Medical License 2022 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Pathology - Molecular Genetic
Awards, Honors, & Recognition
- Patient Safety Star Award Stanford Health Care, 2019
- Howard A. McCordock Prize in Pathology Washington University School of Medicine in St. Louis, 2014
- Antoinette Frances Dames Award in Cell Biology and Physiology Washington University School of Medicine in St. Louis, 2013
- Join now to see all
Publications & Presentations
PubMed
- Real word outcomes of cabozantinib therapy in poorly differentiated thyroid carcinoma.Omar Elghawy, Adam Barsouk, Jessica Xu, Simon Chen, Roger B Cohen
European Thyroid Journal. 2024-12-01 - 7 citationsmutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.C Cameron Yin, Wayne Tam, Serena M Walker, Amandeep Kaur, Madhu M Ouseph
Haematologica. 2024-06-01 - 47 citationsInternational Consensus Statement on Allergy and Rhinology: Sinonasal Tumors.Edward C Kuan, Eric W Wang, Nithin D Adappa, Daniel M Beswick, Nyall R London Jr
International Forum of Allergy & Rhinology. 2024-02-01
Journal Articles
- High levels of CD47 expression in thymic epithelial tumors11. Sun TY, Nguyen B, Chen SB, Natkunam Y, Padda S, van de Rijn M, West R, Neal JW, Wakelee H, Riess JW, JTO Clinical and Research Reports, 3/2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
